Centre Publications

2012

Please click here for publications from the current year

Please click here for publications from other years

Author(s) Title Year Citation
Soh SE, Cook AR, Chen MI, Lee VJ, Cutter JL, Chow VT, Tee NW, Lin RT, Lim WY, Barr IG, Lin C, Phoon MC, Ang LW, Sethi SK, Chong CY, Goh LG, Goh DL, Tambyah PA, Thoon KC, Leo YS and Saw SM Teacher led school-based surveillance can allow accurate tracking of emerging infectious diseases - evidence from serial cross-sectional surveys of febrile respiratory illness during the H1N1 2009 influenza pandemic in Singapore 2012 BMC Infect Dis 12: 336.  PubMed link
Barr IG and Jelley LL The coming era of quadrivalent human influenza vaccines: who will benefit? 2012 Drugs 72(17): 2177-2185. 
PubMed link
DOI:10.2165/11641110-000000000-00000
Hurt AC, Butler J, Kelso A and Barr IG Influenza antivirals and resistance: the next 10 years? 2012 Expert Rev Anti Infect Ther 10(11): 1221-1223. 
PubMed link
DOI:10.1586/eri.12.125
Short KR, Brooks AG, Reading PC and Londrigan SL The fate of influenza A virus after infection of human macrophages and dendritic cells 2012 J Gen Virol 93(Pt 11): 2315-2325. 
PubMed link
DOI: 10.1099/vir.0.045021-0
Kelso A and Hurt AC The ongoing battle against influenza: drug-resistant influenza viruses: why fitness matters 2012 Nat Med 18(10): 1470-1471. 
PubMed link
DOI: 10.1038/nm.2954
Klimov AI, Garten R, Russell C, Barr IG, Besselaar TG, Daniels R, Engelhardt OG, Grohmann G, Itamura S, Kelso A, McCauley J, Odagiri T, Smith D, Tashiro M, Xu X, Webby R, Wang D, Ye Z, Yuelong S, Zhang W and Cox N WHO recommendations for the viruses to be used in the 2012 Southern Hemisphere Influenza Vaccine: epidemiology, antigenic and genetic characteristics of influenza A(H1N1)pdm09, A(H3N2) and B influenza viruses collected from February to September 2011 2012 Vaccine 30(45): 6461-6471. 
PubMed link
DOI:S0264-410X(12)01135-8 [pii] 10.1016/j.vaccine.2012.07.089
Short KR, Reading PC, Wang N, Diavatopoulos DA and Wijburg OL Increased nasopharyngeal bacterial titers and local inflammation facilitate transmission of Streptococcus pneumoniae 2012 MBio 3(5). 
PubMed link
DOI: 10.1128/mBio.00255-12
Meijer A, Jonges M, van Beek P, Swaan C, Osterhaus A, Daniels R, Hurt A and Koopmans M Oseltamivir-resistant influenza A(H1N1)pdm09 virus in Dutch travellers returning from Spain, August 2012 2012 Euro Surveill 17(36). 
PubMed link
Hurt AC, Hardie K, Wilson NJ, Deng YM, Osbourn M, Leang SK, Lee RT, Iannello P, Gehrig N, Shaw R, Wark P, Caldwell N, Givney RC, Xue L, Maurer-Stroh S, Dwyer DE, Wang B, Smith DW, Levy A, Booy R, Dixit R, Merritt T, Kelso A, Dalton C, Durrheim D and Barr IG Characteristics of a widespread community cluster of H275Y oseltamivir-resistant A(H1N1)pdm09 influenza in Australia 2012 J Infect Dis 206(2): 148-157. 
PubMed link
DOI: 10.1093/infdis/jis337
Wang B, Taylor J, Ratnamohan M, McPhie K, Kesson A, Dixit R, Booy R, Hurt A, Saksena N and Dwyer D Frequency of oseltamivir resistance in Sydney, during the Newcastle outbreak of community transmitted oseltamivir-resistant influenza A(H1N1)pdm09 virus, Australia, June to August 2011 2012 Euro Surveill 17(27): pii: 20210. 
PubMed link
Londrigan SL, Tate MD, Brooks AG and Reading PC Cell-surface receptors on macrophages and dendritic cells for attachment and entry of influenza virus 2012 J Leukoc Biol 92(1): 97-106. 
PubMed link
DOI: 10.1189/jlb.1011492
Mulley WR, Visvanathan K, Hurt AC, Brown FG, Polkinghorne KR, Mastorakos T, Lewicki MC, Stuart RL, Tan SJ, Chean R, Kerr PG and Kanellis J Mycophenolate and lower graft function reduce the seroresponse of kidney transplant recipients to pandemic H1N1 vaccination 2012 Kidney Int 82(2): 212-219. 
PubMed link
DOI:10.1038/ki.2012.106
Members of the Western Pacific Region Global Influenza Surveillance and Response System Epidemiological and virological characteristics of influenza in the Western pacific region of the world health organization, 2006-2010 2012 PLoS One 7(5): e37568. 
PubMed link
DOI:10.1371/journal.pone.0037568
Rockman S, Middleton DJ, Pearse MJ, Barr IG, Lowther S and Brown LE Control of pandemic (H1N1) 2009 influenza virus infection of ferret lungs by non-adjuvant-containing pandemic and seasonal vaccines 2012 Vaccine 30(24): 3618-3623. 
PubMed link
DOI:S0264-410X(12)00433-1 [pii] 10.1016/j.vaccine.2012.03.043
Ng WC, Tate MD, Brooks AG and Reading PC Soluble host defense lectins in innate immunity to influenza virus 2012 J Biomed Biotechnol 2012: 732191. 
PubMed link
DOI:10.1155/2012/732191
Arzey GG, Kirkland PD, Arzey KE, Frost M, Maywood P, Conaty S, Hurt AC, Deng YM, Iannello P, Barr I, Dwyer DE, Ratnamohan M, McPhie K and Selleck P Influenza virus A (H10N7) in chickens and poultry abattoir workers, Australia 2012 Emerg Infect Dis 18(5): 814-816. 
PubMed link
DOI:10.3201/eid1805.111852
Deng YM, Iannello P, Smith I, Watson J, Barr IG, Daniels P, Komadina N, Harrower B and Wong FY Transmission of influenza A(H1N1) 2009 pandemic viruses in Australian swine 2012 Influenza Other Respi Viruses 6(3): e42-47. 
PubMed link
DOI:10.1111/j.1750-2659.2012.00337.x
Hsu AC, Parsons K, Barr I, Lowther S, Middleton D, Hansbro PM and Wark PA Critical role of constitutive type I interferon response in bronchial epithelial cell to influenza infection 2012 PLoS One 7(3): e32947. 
PubMed link
DOI:10.1371/journal.pone.0032947
WHO Writing Group, Ampofo WK, Baylor N, Cobey S, Cox NJ, Daves S, Edwards S, Ferguson N, Grohmann G, Hay A, Katz J, Kullabutr K, Lambert L, Levandowski R, Mishra AC, Monto A, Siqueira M, Tashiro M, Waddell AL, Wairagkar N, Wood J, Zambon M and Zhang W Improving influenza vaccine virus selection: report of a WHO informal consultation held at WHO headquarters, Geneva, Switzerland, 14-16 June 2010 2012 Influenza Other Respi Viruses 6(2): 142-152, e141-145. 
PubMed link
DOI:10.1111/j.1750-2659.2011.00277.x
Hurt AC, Chotpitayasunondh T, Cox NJ, Daniels R, Fry AM, Gubareva LV, Hayden FG, Hui DS, Hungnes O, Lackenby A, Lim W, Meijer A, Penn C, Tashiro M, Uyeki TM and Zambon M Antiviral resistance during the 2009 influenza A H1N1 pandemic: public health, laboratory, and clinical perspectives 2012 Lancet Infect Dis 12(3): 240-248. 
PubMed link
DOI: 10.1016/S1473-3099(11)70318-8
Verity EE, Camuglia S, Agius CT, Ong C, Shaw R, Barr I, Middleton D and Rockman S Rapid generation of pandemic influenza virus vaccine candidate strains using synthetic DNA 2012 Influenza Other Respi Viruses 6(2): 101-109. 
PubMed link
DOI:10.1111/j.1750-2659.2011.00273.x
Hurt AC, Okomo-Adhiambo M and Gubareva LV The fluorescence neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors 2012 Methods Mol Biol 865: 115-125. 
PubMed link
DOI:10.1007/978-1-61779-621-0_7
Okomo-Adhiambo M, Hurt AC and Gubareva LV The chemiluminescent neuraminidase inhibition assay: a functional method for detection of influenza virus resistance to the neuraminidase inhibitors 2012 Methods Mol Biol 865: 95-113. 
PubMed link
DOI:10.1007/978-1-61779-621-0_6
Kelso A CD4+ T cells limit the damage in influenza 2012 Nat Med 18(2): 200-202. 
PubMed link
DOI:10.1038/nm.2654
Tate MD, Brooks AG, Reading PC and Mintern JD Neutrophils sustain effective CD8+ T-cell responses in the respiratory tract following influenza infection 2012 Immunol Cell Biol 90(2): 197-205. 
PubMed link
DOI:10.1038/icb.2011.26
Hurt AC, Leang SK, Speers DJ, Barr IG and Maurer-Stroh S Mutations I117V and I117M and oseltamivir sensitivity of pandemic (H1N1) 2009 viruses 2012 Emerg Infect Dis 18(1): 109-112. 
PubMed link
DOI:10.3201/eid1801.111079
WHO/OIE/FAO H5N1 Working Group Continued evolution of highly pathogenic avian influenza A (H5N1): updated nomenclature 2012 Influenza Other Respi Viruses 6(1): 1-5. 
PubMed link
DOI:10.1111/j.1750-2659.2011.00298.x

Top of Page